dentist oral surgery dental implant surgery mouth surgery tooth implant procedure dental news
Tuesday, December 3, 2013
Edimer Initiates Phase 2 Trial of EDI200 in XLHED-Affected Male Newborns
– First neonate subject with X-linked hypohidrotic ectodermal dysplasia completes dosing with the novel ectodysplasin replacement protein EDI200 – Cambridge, Mass. – Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment